Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ONCOCHECK

Financiado

Cerrado

A simple blood test to monitor disease progression in patients undergoing cancer...

A simple blood test to monitor disease progression in patients undergoing cancer therapy The ultimate objective of the ONCOCHECK project is to bring to the healthcare market a unique solution for cancer monitoring which is a simple blood test that will allow oncologist the evaluation of disease progression in patients... ver más

31/10/2015

LIFE LENGTH

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

LIFE LENGTH La prestacion y comercializacion, directa o a traves de terceros con quienes a tal efecto contrate, de servicios de mediacion de la longitud...

TRL 3-4 | 558K€

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2015-10-31

PHC-12-2015-1: Clinical research for the validatio...

I+D

Cerrada hace 9 años

0% 70% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

LIFE LENGTH

50.00K€ | Lider

Proyectos interesantes

ONCOCHECK

Medical Technol...

Data Science

3M€ Cerrado

ThruBlood

Medical Technol...

Biomedical Imag...

71K€ Cerrado

CytoPro

Medical Technol...

Data Science

2M€ Cerrado

IPT-2011-1569-010000

Medical Technol...

Medical Devices

372K€ Cerrado

DETERMINACION Y VALIDACIÓN DE NUEVAS ALTERACI...

Medical Technol...

Biomedical Imag...

30K€ Cerrado

VALID-SCREEN

Medical Technol...

Data Science

3M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 1 meses Fecha Inicio: 2015-09-02
Fecha Fin: 2015-10-31

Líder del proyecto

LIFE LENGTH La prestacion y comercializacion, directa o a traves de terceros con quienes a tal efecto contrate, de servicios de mediacion de la longitud...

TRL 3-4 | 558K€

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The ultimate objective of the ONCOCHECK project is to bring to the healthcare market a unique solution for cancer monitoring which is a simple blood test that will allow oncologist the evaluation of disease progression in patients affected by the great majority of cancers, with no distinction between haematological of solid tumours. Our test will be based on the determination of telomere length in peripheral blood, which is a cancer biomarker that has been identified in the great majority of cancers. The ONCOCHECK test will offer to the healthcare community a test that is simpler (blood test), less costly (200€/test) and more effective (regular monitoring will lead to improved efficiency) as an alternative to other cancer monitoring alternatives that are expensive (2.000-5.000€), complex (need for specialized and very expensive equipment) and less effective (impossible to be performed regularly) imaging techniques conventionally used in the clinic. Moreover, the great advantage of the ONCOCHECK tests over other newly developed competing blood tests based on validated biomarkers is that ONCOCHECK will serve for monitoring all types of cancer, while competing biomarker based solutions are useful only for a specific cancer/tumour. Therefore, Life Length´s test will offer a universal solution for cancer monitoring, with no competitors offering a similar approach. Considering that there are more than 35 million of people affected by cancer all over the world and that the ONCOCHECK will serve for monitoring all cancer types, the business opportunity seems unquestionable. Through the ONCOCHECK project, we seek positioning our company as a leading player on the Advanced Next Generation Cancer Diagnostic Market, which is estimated globally at €5.3 billion in 2015 and expected to reach €10 billion by 2019, representing a huge opportunity for us.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores